A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis

被引:86
作者
Parks, JH [1 ]
Goldfisher, E
Asplin, JR
Coe, FL
机构
[1] Univ Chicago, Nephrol Sect, Chicago, IL 60637 USA
[2] LithoLink Corp, Chicago, IL USA
[3] Hudson Valley Urol, Poughkeepsie, NY USA
关键词
kidney; kidney calculi; metabolism; urine; diagnosis;
D O I
10.1016/S0022-5347(05)65163-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We determined the adequacy of a single 24-hour urine sample for evaluating patients for medical renal stone prevention. Materials and Methods: A total of 459 patients from a private urology practice specializing in the treatment of urolithiasis and 683 from a university stone research clinic provided 2 and 3, 24-hour urine samples, respectively. We used samples 1 and 2 from private practice patients, and I and 3 from university clinic patients for analysis, and compared each to the others by correlation coefficients and calculation of the mean difference plus or minus standard deviation (SD) of the difference. Urine risk factors were measured by standard methods. Results: Although the correlation of urine values 1 and 2 was excellent for all stone risk factors, SD values for the differences were large enough that within 1 SD on either side of 0, which included 68.8% of cases, by chance urine 1 would depart from urine 2 by clinically important amounts. These departures would be more than sufficient to misdiagnose common metabolic disorders. Conclusions: A single 24-hour sample is not sufficient for evaluating patients before metabolic treatment for stone prevention because misdiagnosis is common, leading to inappropriate treatment.
引用
收藏
页码:1607 / 1612
页数:6
相关论文
共 17 条
[1]   Supersaturation and stone composition in a network of dispersed treatment sites [J].
Asplin, J ;
Parks, J ;
Lingeman, J ;
Kahnoski, R ;
Mardis, H ;
Lacey, S ;
Goldfarb, D ;
Grasso, M ;
Coe, F .
JOURNAL OF UROLOGY, 1998, 159 (06) :1821-1825
[2]   RANDOMIZED DOUBLE-BLIND-STUDY OF POTASSIUM CITRATE IN IDIOPATHIC HYPOCITRATURIC CALCIUM NEPHROLITHIASIS [J].
BARCELO, P ;
WUHL, O ;
SERVITGE, E ;
ROUSAUD, A ;
PAK, CYC .
JOURNAL OF UROLOGY, 1993, 150 (06) :1761-1764
[3]   Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study [J].
Borghi, L ;
Meschi, T ;
Amato, F ;
Briganti, A ;
Novarini, A ;
Giannini, A .
JOURNAL OF UROLOGY, 1996, 155 (03) :839-843
[4]  
BORGHI L, 1993, J CARDIOVASC PHARM, V22, pS78
[5]   New insights into the pathophysiology and treatment of nephrolithiasis: New research venues [J].
Coe, FL ;
Parks, JH .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (04) :522-533
[6]   CHLORTHALIDONE REDUCES CALCIUM-OXALATE CALCULOUS RECURRENCE BUT MAGNESIUM-HYDROXIDE DOES NOT [J].
ETTINGER, B ;
CITRON, JT ;
LIVERMORE, B ;
DOLMAN, LI .
JOURNAL OF UROLOGY, 1988, 139 (04) :679-684
[7]   RANDOMIZED TRIAL OF ALLOPURINOL IN THE PREVENTION OF CALCIUM-OXALATE CALCULI [J].
ETTINGER, B ;
TANG, A ;
CITRON, JT ;
LIVERMORE, B ;
WILLIAMS, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (22) :1386-1389
[8]   Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis [J].
Preminger, GM .
JOURNAL OF UROLOGY, 1997, 158 (06) :2073-2073
[9]   PHYSICOCHEMICAL ASPECTS OF UROLITHIASIS [J].
FINLAYSON, B .
KIDNEY INTERNATIONAL, 1978, 13 (05) :344-360
[10]  
HAMM LL, 1996, KIDNEY STONES MED SU, P289